“…Patients with sepsis and septic shock treated with methylene blue exhibit reduced time until vasopressor discontinuation, reduced length of stay in the intensive care unit, and reduced days on mechanical ventilation as compared to placebo. In a retrospective study evaluating the effect of methylene blue in shock, reduced 28-day mortality in critically ill patients was noted when methylene blue was administered as a bolus followed by a continuous infusion [ 19 , 20 , 21 ].…”